⁦ @nytimes⁩ buries the lede but this is a doozie:

associates of Trump’s have financial interests in the issue. Sanofi’s largest shareholders include Fisher Asset Management, mutual fund company run by Ken Fisher, major donor to GOP, including Trump. https://www.nytimes.com/2020/04/06/us/politics/coronavirus-trump-malaria-drug.html">https://www.nytimes.com/2020/04/0...

Another investor in both Sanofi & Mylan, another pharmaceutical firm, is Invesco, the fund previously run by Wilbur Ross, the commerce secretary.

https://abs.twimg.com/emoji/v2/... draggable="false" alt="🚨" title="Police cars revolving light" aria-label="Emoji: Police cars revolving light">https://abs.twimg.com/emoji/v2/... draggable="false" alt="🚨" title="Police cars revolving light" aria-label="Emoji: Police cars revolving light"> As of last year, Mr. Trump reported that his three family trusts each had investments in a Dodge & Cox mutual fund, whose largest holding was in Sanofi.https://abs.twimg.com/emoji/v2/... draggable="false" alt="🚨" title="Police cars revolving light" aria-label="Emoji: Police cars revolving light">https://abs.twimg.com/emoji/v2/... draggable="false" alt="🚨" title="Police cars revolving light" aria-label="Emoji: Police cars revolving light">

Several generic drugmakers are gearing up to produce hydroxychloroquine pills, including Amneal Pharmaceuticals, whose co-founder Chirag Patel is a member of Trump National Golf Course Bedminster in New Jersey and has golfed with Mr. Trump at least twice since he became president

Roberto Mignone, a Teva board member, reached out to the team of Jared Kushner, the president’s son-in-law and senior adviser, through Nitin Saigal, who used to work for Mr. Mignone and is a friend of Mr. Kushner’s, according to people informed about the discussions.

Kushner’s team referred him to the White House task force & Mignone asked for help getting India to ease export restrictions, which have since been relaxed, allowing Teva to bring more pills into the United States.

Dr. Daniel Sterman, critical care director at NYU Langone Health, said doctors are using hydroxychloroquine, but data about its effectiveness remained “weak & unsubstantiated” pending study. “We do not know whether our patients are benefiting from hydroxychloroquine treatment.”